These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 17126957)

  • 1. Vaccination associated thrombocytopenic purpura in children.
    Rajantie J; Zeller B; Treutiger I; Rosthöj S;
    Vaccine; 2007 Feb; 25(10):1838-40. PubMed ID: 17126957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK; Glanz J; Xu S; Hambidge S; Yamasaki K; Black SB; Marcy M; Mullooly JP; Jackson LA; Nordin J; Belongia EA; Hohman K; Chen RT; Davis R;
    Pediatrics; 2008 Mar; 121(3):e687-92. PubMed ID: 18310189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMR vaccine and idiopathic thrombocytopaenic purpura.
    Black C; Kaye JA; Jick H
    Br J Clin Pharmacol; 2003 Jan; 55(1):107-11. PubMed ID: 12534647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature.
    Owatanapanich S; Wanlapakorn N; Tangsiri R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1053-7. PubMed ID: 25417506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
    O'Leary ST; Glanz JM; McClure DL; Akhtar A; Daley MF; Nakasato C; Baxter R; Davis RL; Izurieta HS; Lieu TA; Ball R
    Pediatrics; 2012 Feb; 129(2):248-55. PubMed ID: 22232308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.
    Mantadakis E; Farmaki E; Buchanan GR
    J Pediatr; 2010 Apr; 156(4):623-8. PubMed ID: 20097358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic thrombocytopenic purpura and the second dose of MMR.
    Stowe J; Kafatos G; Andrews N; Miller E
    Arch Dis Child; 2008 Feb; 93(2):182-3. PubMed ID: 17962371
    [No Abstract]   [Full Text] [Related]  

  • 8. Outcome of children with idiopathic thrombocytopenic purpura, based on original material.
    Zawitkowska-Klaczyńska J; Nurzyńska-Flak J; Kattski K; Kowalczyk JR
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):194-7. PubMed ID: 16146076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000].
    Kjaersgaard M; Edslev PW; Rosthøj S
    Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between drug and vaccine use and acute immune thrombocytopenia in childhood: a case-control study in Italy.
    Bertuola F; Morando C; Menniti-Ippolito F; Da Cas R; Capuano A; Perilongo G; Da Dalt L
    Drug Saf; 2010 Jan; 33(1):65-72. PubMed ID: 20000868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children.
    Glanz J; France E; Xu S; Hayes T; Hambidge S
    Pediatrics; 2008 Mar; 121(3):e506-12. PubMed ID: 18310170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic thrombocytopenic purpura and MMR vaccine.
    Miller E; Waight P; Farrington CP; Andrews N; Stowe J; Taylor B
    Arch Dis Child; 2001 Mar; 84(3):227-9. PubMed ID: 11207170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)].
    Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG
    Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine administration and the development of immune thrombocytopenic purpura in children.
    Cecinati V; Principi N; Brescia L; Giordano P; Esposito S
    Hum Vaccin Immunother; 2013 May; 9(5):1158-62. PubMed ID: 23324619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?
    Bibby AC; Farrell A; Cummins M; Erlewyn-Lajeunesse M
    Arch Dis Child; 2008 Apr; 93(4):354-5. PubMed ID: 18356391
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lack of association between MMR vaccination and the incidence of autism in children: a case-control study].
    Mrozek-Budzyn D; Kiełtyka A; Majewska R
    Przegl Epidemiol; 2009; 63(1):107-12. PubMed ID: 19522237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.
    Page LK; Psaila B; Provan D; Michael Hamilton J; Jenkins JM; Elish AS; Lesser ML; Bussel JB
    Br J Haematol; 2007 Jul; 138(2):245-8. PubMed ID: 17542983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia.
    Roganovic J; Letica-Crepulja M
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina.
    Donato H; Picón A; Martinez M; Rapetti MC; Rosso A; Gomez S; Rossi N; Bacciedoni V; Schvartzman G; Riccheri C; Costa A; Di Santo J
    Pediatr Blood Cancer; 2009 Apr; 52(4):491-6. PubMed ID: 19058214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia after immunization of Canadian children, 1992 to 2001.
    Jadavji T; Scheifele D; Halperin S;
    Pediatr Infect Dis J; 2003 Feb; 22(2):119-22. PubMed ID: 12586974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.